drug
plecanatide
Marketedupdated 3mo agoby Salix Pharmaceuticals Ltd
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying plecanatide
- phase2This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC
- phase2Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)
- phase3Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 30, 2028
~1.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (10)
- Jun 5, 2034compositionUS 10011637
- Jun 5, 2034formulationUS 11142549
- Jun 5, 2034formulationUS 11834521
- Jun 5, 2034formulationUS 12146003
- Aug 20, 2032formulationUS 9616097
- Mar 1, 2032formulationUS 11319346
- Sep 15, 2031method-of-use (U-2230)US 9610321
- Sep 15, 2031method-of-use (U-1999)US 9919024
- Sep 15, 2031formulationUS 9925231
- Jan 30, 2028compositionUS 70417861.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that